, ,

View On Demand

Creating An Industrial Scale Platform For Cell Therapies

About the Event

The promise of using pluripotent stem cells to treat people who may otherwise live the rest of their lives with incurable disease is starting to be realized. But as with any new technology, the applications are limited, and cost is a barrier to widespread adoption of the treatments.

LizarBio has developed a new method for creating tissue-authentic cells with high regenerative potential for a fraction of the cost of current technology. This allows them to cultivate and differentiate cells at industrial scale which will unlock the promise of the regenerative medicine by making curative therapies available to hundreds of thousands of patients per year.

Join our webinar to hear LizarBio CEO, Marcos Valadares share the details of their innovative process, how it significantly reduces costs and speeds pluripotent cell development, and the ongoing programs to treat heart disease and Rhett Syndrome.

Watch On-Demand Webinar


All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.